A total of 390 more persons tested coronavirus positive in Jammu and Kashmir on Monday while 482 patients were discharged from different hospitals after...
Drugmaker Johnson & Johnson has launched the Phase 3 trials of the two-dose regimen of its investigational vaccine candidate for the prevention of Covid-19.
The...
The investigational drug 'evolocumab' reduces low-density lipoprotein (LDL) 'bad' cholesterol by 50 percent in patients with severe hypercholesterolemia, researchers said.
Hypercholesterolemia, also called high cholesterol,...